World-First Trial To Test Benefit Of Intravenous Zinc In COVID-19 Fight
A world-first trial will see researchers from Austin Health and the University of Melbourne use Phebra’s intravenous zinc to fight the symptoms of coronavirus (COVID-19).
A world-first trial will see researchers from Austin Health and the University of Melbourne use Phebra’s intravenous zinc to fight the symptoms of coronavirus (COVID-19).